Hi, Tim Plaehn here.
Silver just shattered prices records last year.
And I've found a way to play this surge....
It's a simple silver fund that's been quietly delivering up to 20% in yearly distributions… Paid monthly.
That means while others wait for silver to go higher…
You could already be collecting $1,170 a month.
Click here to discover how this silver income fund works.
The next payout is just days away.
To your income,
Tim Plaehn
Lead Income Strategist
Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
Written by Leo Miller. Date Posted: 5/13/2026.
Key Points
- Interesting insider trades have recently hit three key stocks experiencing very different near-term performance.
- Insiders are purchasing shares of cybersecurity stock Okta, and healthcare giant Abbott.
- Meanwhile, after a historically strong run, Micron's insider selling has increased in Q2.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Insiders are making moves in three stocks that have seen major swings in value in recent months. That includes insider buying in names that have fallen more than 30% and sales in one of the market’s hottest tech stocks. Here are the signals insiders are sending to investors in Q2.
As AI Fears Weigh on Okta, an Insider Steps In
First up is Okta (NASDAQ: OKTA), a stock that has struggled considerably. Compared with its 52-week high, Okta is down almost 40%. One of the key drivers has been fears about the effect artificial intelligence (AI) will have on the cybersecurity sector.
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions.
See the 5 stocks to avoidThe market is running scared, driven by the idea that AI models will solve many of the problems cybersecurity companies have built businesses around. However, there is also an argument that, when put in the wrong hands, AI models increase cyber risk, potentially making these companies more important than ever.
Amid Okta’s struggles, one insider is clearly showing confidence in the business. In Q2, Director David Schellhase purchased around $267,000 worth of Okta stock, a bullish indicator. Still, investors will notice that insider sales in Q2 have considerably outweighed his purchase, at $1.2 million. However, the details here are interesting.
The sales and purchases both came under predetermined 10b5-1 plans. When it comes to 10b5-1 sales, the negative signal they send is somewhat limited, as they are often used by insiders simply to gain liquidity over time.
On the other hand, insiders tend to buy their company’s stock only if they think the price will rise. As a result, 10b5-1 plan buys are still bullish, and potentially even more so than non-10b5-1 buys. They signal sustained conviction, as future purchases through this plan are likely to occur.
Micron’s Insider Selling: Red Flag or Non-Issue?
Micron Technology (NASDAQ: MU) was one of the market's best-performing stocks in 2025 and has continued to move sharply higher in 2026. After notching a 240% gain in 2025, shares have already appreciated more than 170% so far in 2026. The reason for Micron’s rise is well documented: memory chips are in short supply, while demand from AI data centers is intense.
These dynamics have led to Micron posting some astonishing financial metrics. In its latest quarter, Micron’s revenue rose by 196% year over year (YOY) to a record $23.9 billion. Meanwhile, earnings per share rose by 682% YOY to $12.20.
However, the company is also seeing some notable insider activity in Q2. Insider sales have approximately doubled from Q1, rising to $45 million versus $22 million last quarter. The company has also not seen any insider buys, compared with $7.8 million in buys during Q1.
Still, the majority, or $35 million, of these sales came under a 10b5-1 plan. Sumit Sadana’s $10.1 million sale did not. However, Sadana’s sale was a moderate trim rather than an exit, representing around 10% of his holdings. Overall, while not positive, the mitigating factors make Micron’s recent sales not overly concerning.
Abbott Insiders Send Bullish Signals as Shares Plummet in 2026
Last up is Abbott Laboratories (NYSE: ABT), one of the world’s largest names in healthcare equipment and supplies. Abbott is another stock experiencing weakness, down more than 20% since the start of 2025 and down over 30% in 2026.
Abbott’s recent earnings reports were significant contributors to the stock’s decline. In Q4 2025, Abbott posted mixed results, with in-line adjusted earnings per share (EPS) of $1.50 but revenue that fell below expectations by $342 million.
The company’s guidance for 2026 was essentially in line with estimates. However, markets focused on the miss, pushing Abbott shares down 10% in reaction. Its Q1 2026 results saw top- and bottom-line beats, but Abbott lowered its full-year EPS guidance, leading shares to fall 6%.
However, multiple insiders are picking up the slack in this stock, with total insider purchases of $1.13 million in Q2. This adds to buying in Q1, which came in at $1.09 million, and MarketBeat has tracked no insider sales in Q2 thus far.
The uptick in purchases clearly coincides with Abbott’s significant 2026 decline, which has been a big drag on longer-term performance. This suggests insiders are buying what they likely see as a dip in Abbott stock, a positive sign going forward.
Analysts Eye Solid Upside in Abbott Amid 2026 Slide
Trades surrounding Micron do not send a strong signal. However, buys at Okta and Abbott are worth noticing. Importantly, investors should remember that insider transactions are just one tool for assessing the future of individual stocks. They are not declarations of how these names will move going forward.
Still, Wall Street analysts are echoing the sentiment of insiders when it comes to Abbott. The MarketBeat consensus price target on shares near $119 implies more than 40% upside in the stock. Targets updated after the company’s latest earnings report are similarly bullish. The average of these targets is just slightly lower than the consensus, at approximately $118.
D-Wave Earnings Looked Weak, But Investors May Be Missing This
Written by Nathan Reiff. Date Posted: 5/13/2026.
Key Points
- D-Wave shares fell about 7% in a single day following a seemingly disappointing earnings report including news of an 80% YOY decline to revenue.
- Still, bookings were up considerably, with growing QCaaS revenue as a standout.
- D-Wave's performance stands in stark contrast to Rigetti Computing, which saw revenue roughly triple YOY in the first quarter.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Earnings season is a pivotal moment for many stocks, but especially for companies in an emerging industry like quantum computing. When major player IonQ Inc. (NYSE: IONQ) reported results for the first quarter of 2026 in early May, investors took note of promising revenue growth, an increase to full-year guidance versus prior projections, and strong progress in both partnerships and system sales. Still, a crucial piece of the puzzle—profitability—remains missing.
Now, other big names in the pure-play quantum space are sharing their own results, including firms such as D-Wave Quantum Inc. (NYSE: QBTS) and Rigetti Computing (NASDAQ: RGTI). D-Wave, known for its sizable cash holdings and recent purchase of Quantum Circuits Inc., stands out for its dual focus on two distinct approaches to quantum computing.
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions.
See the 5 stocks to avoidLike IonQ, the company reported several encouraging developments in its Q1 2026 earnings, particularly in bookings, sales pipeline growth, and technological advances.
However, top- and bottom-line performance may have contributed to a post-earnings selloff that sent the share price down 7% on May 12, reversing the recent mini-rally that began in April.
The Bright Spots in D-Wave's Earnings: Bookings, Recurring Revenue, Sales Pipeline, and More
A number of highlights emerge from a closer look at D-Wave's first quarter of the new year. Notably, quarterly bookings reached $33.4 million, a record for Q1 and a massive increase of about 2,000% year-over-year (YOY). That figure is impressive on its own, but one of the real strengths here is D-Wave's growth in its quantum-computing-as-a-service (QCaaS) business, which climbed 15% YOY to $1.8 million in revenue. QCaaS positions D-Wave to build recurring revenue into its business model, which could be crucial in its efforts to achieve sustainable profitability. A $10 million enterprise QCaaS agreement in Q1 was a major driver of that growth.
The company's sales pipeline is also looking strong, with growth of more than 100% sequentially in Q1 2026. D-Wave sees system sales—the lion's share of its revenue so far—totaling two or three per year going forward, with at least two projected for 2026. These big-ticket sales do not necessarily create recurring revenue, but they vastly outsize the firm's other revenue streams at this point.
Technological advances are also crucial for any quantum computing company, and D-Wave highlighted several important ones in the first three months of the year. A standout achievement is the company's roadmap to 100 logical qubits, a major technological breakthrough it believes can be achieved by 2032.
Finally, investors have been watching closely to see whether D-Wave has maintained its historically strong cash position. With more than $588 million in cash and equivalents at the end of the quarter, the company's reserves remain healthy.
The Reason for the Share Price Decline
It's difficult for D-Wave to avoid negative headlines given its top- and bottom-line performance in the quarter, despite all of the successes above. Notably, revenue of $2.9 million was down more than 80% YOY and came in about $1.3 million below analyst expectations. Though losses per share beat estimates by 3 cents, they still widened by 3 cents from the prior-year quarter.
A closer look may give long-term D-Wave investors some comfort. Part of the reason for the seemingly massive revenue decline is that Q1 of last year included the sale of a quantum annealing computer system for nearly $13 million. A single transaction can have a major impact on revenue performance, particularly when overall revenue is so low.
Still, D-Wave's sensitivity to the timing of an individual system sale reflects how reliant the company has been on these types of one-off deals. Investors will likely be pleased to see the company move toward a more predictable and consistent revenue stream.
Investors in the quantum computing space will need to decide whether D-Wave remains a suitable target based on its performance relative to its peers. For one thing, Rigetti announced on the same day that its Q1 2026 revenue roughly tripled YOY to $4.4 million.
The path toward profitability may be somewhat clearer based on QCaaS performance, but widening losses and the sizable gap between expected revenue and actual results suggest that there may still be significant ground to cover.
D-Wave shares remain a Moderate Buy, with 14 out of 17 analysts bullish on the stock.
This email content is a paid sponsorship for Investors Alley, a third-party advertiser of Earnings360 and MarketBeat.
If you have questions about your newsletter, please contact our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103-7078. USA..
Post a Comment
0Comments